Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

lidocaine 5% patch. Pain Medicine News ... proposed joint venture with IPMC Company), and non-opioid pain management products for acute and chronic pain, today announced that it has voluntarily ...

and commonly the opioids patches and NSAIDS are prescribed which are proven to be effective in chronic pain management. However, the OTC Medicines segment is projected to manifest the highest CAGR ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of ...

In contrast, patients using the 5% patch saw a substantial increase in opioid use from baseline (+42.9%; P Scilex Holding Company is engaged in the acquisition, development, and commercialization of ...

Alyea is developing innovative, actionable solutions intended to help end the opioid crisis ... approach to treating pain through non-addictive and non-sedating means, with additional potential broad ...